nach oben

Reactions Weekly

Erschienen in:

01.03.2019 | Case report

Bevacizumab/dexamethasone

Striae distensae and skin ulcer successfully treated with diltiazem: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

An 11-year-old child [sex not stated] developed striae distensae during treatment with dexamethasone for astrocytoma. Additionally, the child developed ulceration of striae distensae during treatment with bevacizumab [routes not stated; not all duration of treatments to reactions onsets and dosages stated]. The condition was successfully treated with diltiazem. …

Fuentes RC, et al. Topical diltiazem for ulceration of striae distensae associated with bevacizumab therapy. Dermatologic Therapy 32: e12750, No. 1, Feb 2019. Available from: URL: http://doi.org/10.1111/dth.12750 - SpainCrossRefPubMed

Titel: Bevacizumab/dexamethasone
Striae distensae and skin ulcer successfully treated with diltiazem: case report
Publikationsdatum: 01.03.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-59240-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Bevacizumab/dexamethasone

Striae distensae and skin ulcer successfully treated with diltiazem: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Imiquimod

Oxcarbazepine

Hydroxycarbamide

Immune globulin

Ruxolitinib

Blinatumomab/ponatinib